Calumet Operating Income from 2010 to 2026

CLMT Stock

USD 19.89 0.09 0.45%

Calumet Specialty Operating Income yearly trend continues to be comparatively stable with very little volatility. Operating Income will likely drop to about 8.8 M in 2026. Operating Income is earnings before interest and taxes (EBIT), representing the amount of profit Calumet Specialty Products generates from its operations. View All Fundamentals

Operating Income

First Reported

2003-12-31

Previous Quarter

-101 M

Current Value

322.9 M

Quarterly Volatility

55.2 M

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Check Calumet Specialty financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Calumet Specialty's main balance sheet or income statement drivers, such as Depreciation And Amortization of 205.8 M, Interest Expense of 226.8 M or Selling General Administrative of 149.3 M, as well as many indicators such as Price To Sales Ratio of 0.32, Dividend Yield of 0.088 or Days Sales Outstanding of 25.95. Calumet financial statements analysis is a perfect complement when working with Calumet Specialty Valuation or Volatility modules.

Build AI portfolio with Calumet Stock

Check out the analysis of Calumet Specialty Correlation against competitors.

Latest Calumet Specialty's Operating Income Growth Pattern

Below is the plot of the Operating Income of Calumet Specialty Products over the last few years. Operating Income is the amount of profit realized from Calumet Specialty operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Calumet Specialty Products is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. It is earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations. Calumet Specialty's Operating Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Calumet Specialty's overall financial position and show how it may be relating to other accounts over time.

Operating Income

10 Years Trend

Pretty Stable

Compare to Others All Fundamentals

Operating Income

Timeline

Calumet Operating Income Regression Statistics

	Arithmetic Mean	70,636,956
	Geometric Mean	57,805,460
	Coefficient Of Variation	149.28
	Mean Deviation	82,163,223
	Median	75,000,000
	Standard Deviation	105,447,554
	Sample Variance	11119.2T
	Range	371.5M
	R-Value	(0.20)
	Mean Square Error	11363.3T
	R-Squared	0.04
	Significance	0.43
	Slope	(4,275,159)
	Total Sum of Squares	177907T

Calumet Operating Income History

	2026	8.8 M
	2025	9.3 M
	2024	8.1 M
	2023	267.2 M
	2022	131.9 M
	2021	-85.6 M
	2020	-71.9 M

Other Fundumenentals of Calumet Specialty

Non Operating Income Net Other

Calumet Specialty Operating Income component correlations

	Total Assets	Total Stockholder Equity	Total Liab	Accounts Payable	Long Term Debt	Intangible Assets	Property Plant Equipment	Current Deferred Revenue	Net Debt	Net Receivables	Total Current Assets	Short Term Debt	Good Will	Net Tangible Assets	Short Term Investments	Long Term Debt Total	Deferred Long Term Liab	Common Stock	Short Long Term Debt	Net Invested Capital	Net Working Capital
Total Assets		0.02	0.65	0.86	0.67	0.45	0.94	0.32	0.62	0.82	0.74	0.22	0.79	-0.32	0.03	0.73	0.27	0.21	0.19	-0.02	-0.16
Total Stockholder Equity	0.02		-0.64	0.11	-0.52	0.78	-0.12	-0.65	-0.64	0.09	0.19	-0.6	0.06	0.86	-0.86	-0.36	-0.85	0.83	-0.12	0.82	0.77
Total Liab	0.65	-0.64		0.5	0.95	-0.17	0.7	0.72	0.98	0.53	0.4	0.47	0.56	-0.8	0.61	0.78	0.82	-0.32	0.22	-0.59	-0.58
Accounts Payable	0.86	0.11	0.5		0.42	0.36	0.75	0.41	0.41	0.78	0.74	0.2	0.6	-0.15	-0.06	0.4	0.31	0.18	0.03	-0.07	-0.3
Long Term Debt	0.67	-0.52	0.95	0.42		-0.01	0.74	0.55	0.98	0.52	0.36	0.27	0.63	-0.71	0.48	0.88	0.67	-0.16	0.18	-0.43	-0.35
Intangible Assets	0.45	0.78	-0.17	0.36	-0.01		0.34	-0.4	-0.15	0.34	0.31	-0.42	0.63	0.45	-0.69	0.23	-0.58	0.84	-0.07	0.61	0.57
Property Plant Equipment	0.94	-0.12	0.7	0.75	0.74	0.34		0.36	0.7	0.64	0.52	0.21	0.72	-0.44	0.06	0.82	0.34	0.05	0.05	-0.11	-0.24
Current Deferred Revenue	0.32	-0.65	0.72	0.41	0.55	-0.4	0.36		0.67	0.3	0.19	0.56	0.22	-0.71	0.57	0.35	0.8	-0.5	0.07	-0.7	-0.76
Net Debt	0.62	-0.64	0.98	0.41	0.98	-0.15	0.7	0.67		0.49	0.32	0.42	0.55	-0.79	0.59	0.83	0.78	-0.31	0.21	-0.54	-0.5
Net Receivables	0.82	0.09	0.53	0.78	0.52	0.34	0.64	0.3	0.49		0.92	0.34	0.6	-0.19	0.1	0.52	0.24	0.19	0.52	0.09	-0.07
Total Current Assets	0.74	0.19	0.4	0.74	0.36	0.31	0.52	0.19	0.32	0.92		0.27	0.47	-0.06	0.06	0.33	0.11	0.27	0.57	0.16	0.02
Short Term Debt	0.22	-0.6	0.47	0.2	0.27	-0.42	0.21	0.56	0.42	0.34	0.27		0.11	-0.68	0.69	0.29	0.51	-0.66	0.58	-0.56	-0.71
Good Will	0.79	0.06	0.56	0.6	0.63	0.63	0.72	0.22	0.55	0.6	0.47	0.11		-0.33	0.06	0.72	0.2	0.38	0.03	-0.13	-0.1
Net Tangible Assets	-0.32	0.86	-0.8	-0.15	-0.71	0.45	-0.44	-0.71	-0.79	-0.19	-0.06	-0.68	-0.33		-0.85	-0.65	-0.77	0.7	-0.18	0.84	0.76
Short Term Investments	0.03	-0.86	0.61	-0.06	0.48	-0.69	0.06	0.57	0.59	0.1	0.06	0.69	0.06	-0.85		0.31	0.75	-0.73	0.31	-0.85	-0.7
Long Term Debt Total	0.73	-0.36	0.78	0.4	0.88	0.23	0.82	0.35	0.83	0.52	0.33	0.29	0.72	-0.65	0.31		0.4	-0.11	0.23	-0.25	-0.23
Deferred Long Term Liab	0.27	-0.85	0.82	0.31	0.67	-0.58	0.34	0.8	0.78	0.24	0.11	0.51	0.2	-0.77	0.75	0.4		-0.59	0.0	-0.81	-0.82
Common Stock	0.21	0.83	-0.32	0.18	-0.16	0.84	0.05	-0.5	-0.31	0.19	0.27	-0.66	0.38	0.7	-0.73	-0.11	-0.59		-0.11	0.71	0.74
Short Long Term Debt	0.19	-0.12	0.22	0.03	0.18	-0.07	0.05	0.07	0.21	0.52	0.57	0.58	0.03	-0.18	0.31	0.23	0.0	-0.11		0.14	0.08
Net Invested Capital	-0.02	0.82	-0.59	-0.07	-0.43	0.61	-0.11	-0.7	-0.54	0.09	0.16	-0.56	-0.13	0.84	-0.85	-0.25	-0.81	0.71	0.14		0.89
Net Working Capital	-0.16	0.77	-0.58	-0.3	-0.35	0.57	-0.24	-0.76	-0.5	-0.07	0.02	-0.71	-0.1	0.76	-0.7	-0.23	-0.82	0.74	0.08	0.89

Click cells to compare fundamentals

About Calumet Specialty Financial Statements

Calumet Specialty shareholders use historical fundamental indicators, such as Operating Income, to determine how well the company is positioned to perform in the future. Although Calumet Specialty investors may analyze each financial statement separately, they are all interrelated. The changes in Calumet Specialty's assets and liabilities, for example, are also reflected in the revenues and expenses on on Calumet Specialty's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

	Last Reported	Projected for Next Year
Operating Income	9.3 M	8.8 M
Non Operating Income Net Other	-113.3 M	-107.6 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Calumet Stock Analysis

When running Calumet Specialty's price analysis, check to measure Calumet Specialty's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Calumet Specialty is operating at the current time. Most of Calumet Specialty's value examination focuses on studying past and present price action to predict the probability of Calumet Specialty's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Calumet Specialty's price. Additionally, you may evaluate how the addition of Calumet Specialty to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC

Calumet Operating Income from 2010 to 2026

Latest Calumet Specialty's Operating Income Growth Pattern

Calumet Operating Income Regression Statistics

Calumet Operating Income History

Other Fundumenentals of Calumet Specialty

Calumet Specialty Operating Income component correlations

About Calumet Specialty Financial Statements

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for Calumet Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY